Fund manager prescribes AngioDynamics, Magellan Health, KV Pharmaceutical
Fund manager prescribes AngioDynamics, Magellan Health, KV Pharmaceutical
(via www.marketwatch.com)
Jason Ronovech is feeling good about health-care stocks. The co-manager with Jonathan Vyorst of Paradigm Value Fund is finding that the health-care sector holds plenty of the out-of-favor, undervalued companies he seeks.

